Merck struggles to win European approval for Covid antiviral pill
Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications
EMA issues advice on Merck’s Covid treatment and starts to review Pfizer’s tablet
Merck treatment should be given early, regulator says
Merck to move Covid-19 treatment into large trials
Drugmaker more upbeat on full-year impact after sharp drop in medical visits early in the pandemic
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices